Mary Vanac is a co-founder of MedCity News.
Insys Therapeutics, a Phoenix-based drug development company focused on pain and oncology, will swallow Chicago-area biopharmaceutical developer NeoPharm Inc. (OTC:NEOL.PK) through a reverse merger worth an initial $135 million in stock.
Days after rejecting Arena's obesity drug lorcaserin, the FDA has asked for more safety data -- specifically, for pregnant women -- for Vivus' Qnexa, one of three closely watched obesity drugs up for approval, according to FierceBiotech. An expert panel already voted 10-to-6 against approving that drug.
At the Payer Insights sessions on Day 1 of ViVE 2024, a panel on prior authorization offered compelling insights from speakers who shared the positive developments in this area after years of mounting frustration. Speakers also shared challenges as they work with providers to figure out how policy developments and technology will work in practice.
MDG Medical Inc. will move its research and development group to Aurora, Ohio, from Lod, Israel, by the end of March, creating up to 30 jobs. The developer of automated pharmacy technology is one of the first Israeli medical companies to relocate to Northeast Ohio this decade.
Illinois kept its lead among nine states and one region in pursuit of venture capital dollars for Midwest healthcare startups so far this year. Midwestern states won a total of $572 million for their healthcare companies since the beginning of the year, according to the BioEnterprise Midwest Health Care Venture Investment report.
Home healthcare products maker Invacare Corp. (NYSE:IVC) is taking steps -- notably, reducing and refinancing its debt -- to be poised to make acquisitions, as well as return to historic sales growth rates. When might those things happen? Even executives of the Elyria, Ohio, company can't say.
In 2002, drug maker GlaxoSmithKline sent one of its quality-assurance managers to Puerto Rico to help clean up a mess at one of its biggest manufacturing plants. Cheryl Eckard's journey ended this week with the largest ever U.S. whistleblower award -- at least $96 million, the Wall Street Journal reports.
This eBook, in collaboration with Care Logistics, details how hospitals and health systems can facilitate more effective decision-making by operationalizing elevated awareness.
Like other reform supporters, John McDonough believes that the more people know about what's in federal health reform law, the less they will want to see it struck from the books, regardless of which political party emerges as leader in next week's mid-term election, according to Kaiser Health News.
The Wall Street Journal tested three leading online personal health record systems -- Google Health, Microsoft's HealthVault and WebMD's Health Manager. None of the three emerged as a clear winner, though the Journal concluded that PHRs offer "a remarkable value for a free application."
The Food and Drug Administration made it official Saturday, turning a thumbs-down to Lorqess (lorcaserin), the new diet drug by Arena Pharmaceuticals, because of concerns that it may cause tumors in rats and is marginally effective, according to the Pharmalot blog.
Six months after it struck a deal to have Cleveland Clinic doctors perform heart surgeries on its employees and their families, home improvement retailer Lowe's calls early returns on the alliance a "home run." And St. Jude Medical is feeling the momentum mojo.
Canada has a proud history of achievement in the areas of science and technology, and the field of biomanufacturing and life sciences is no exception.
Ann Arbor, Michigan, biopharmaceutical company Cerenis Therapeutics added $13.9 million to a July investment round that it will use to continue clinical trials of a drug to treat heart disease. Cerenis will use its latest investment to do Phase II clinical trial development of CER-001, which mimics high-density lipid ("good") cholesterol and can rapidly reverse atherosclerotic plaque.
Defunding by Congress and implementation by governors are the two major threats facing healthcare reform, Tom Daschle, former U.S. Senate majority leader who almost became Department of Health and Human Services nomination in the Obama administration, tells Kaiser Health News.
Skokie, Illinois, health information technology company RemCare Inc. has closed a $2.7 million Series A round of investment and taken the name of its flagship product -- Care Team Connect.
A September report by Deloitte that predicts the mobile personal health record as the next killer app is wrong, according to a MobiHealthNews panel. "With all due respect.... There is a big problem with the PHR business," Healthrageous Chief Technical Officer Doug McClure said, "consumer engagement is terrible."
An independent study by HealthGrades of patient outcomes at America's hospitals found that patients at 5-star rated hospitals had a 72 percent lower risk of dying when compared with patients at 1-star-rated hospitals -- an enormous gap that has held steady over years even as overall mortality rates improved.